A mutated human tumor necrosis factor-alpha improves the therapeutic index in vitro and in vivo.
- Published Article
- Publication Date
Jan 01, 2006
These results suggest that rmhTNF has potential for developing an effective anti-tumor reagent for some tumors.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/16923618